Haemolytic Disease of the Foetus and Newborn

The challenge

Due to the complexity of investigating Haemolytic Disease of the Foetus and Newborn (HDFN), any inconsistency in laboratory practice presents a significant patient safety risk. Variability in how laboratory scientists perform tests or interpret results can cause at-risk pregnancies to be missed, leading to delayed or inappropriate clinical action and placing the well-being of the foetus and newborn in jeopardy.

The solution

A comprehensive digital learning program providing clinical context to help laboratory scientists to:

• Understand the complete investigative pathway for patients who are pregnant or at risk of HDFN, from initial testing to final analysis
• Master the key serological techniques used to prevent, identify, and characterise the antibodies that cause HDFN
• Apply knowledge to realistic scenarios through interactive case studies that reinforce correct test application and interpretation
• Recognise the critical indicators that necessitate referral to fetal medicine specialists for clinical management